IXHL Financial Statements

Balance sheet, income statement, cash flow, and dividends for Incannex Healthcare Inc (IXHL).


$46.67M Market Cap.

As of 10/01/2024 5:00 PM ET (MRY) • Disclaimer

IXHL Market Cap. (MRY)


IXHL Shares Outstanding (MRY)


IXHL Assets (MRY)


Total Assets

$17.05M

Total Liabilities

$5.83M

Total Investments

$0

IXHL Income (MRY)


Revenue

$12.00K

Net Income

-$18.46M

Operating Expense

$30.05M

IXHL Cash Flow (MRY)


CF Operations

-$15.85M

CF Investing

-$277.00K

CF Financing

$0

IXHL Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

-

0%

0%

-

2020

$0

-

-

0%

-

IXHL Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$17,047,000 (-80.76%)

$88,590,700 (133.87%)

$37,879,608 (306.05%)

$9,328,795 (120.22%)

Assets Current

$16,202,000 (-53.29%)

$34,685,887 (-8.43%)

$37,879,608 (306.05%)

$9,328,795 (120.22%)

Assets Non-Current

$845,000 (-98.43%)

$53,904,813 (0%)

$0 (0%)

$0 (0%)

Goodwill & Intangible Assets

$0 (0%)

$52,717,427 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$11,217,000 (-85.92%)

$79,667,034 (135.29%)

$33,858,542 (333.05%)

$7,818,697 (124.04%)

Property Plant & Equipment Net

$845,000 (-28.84%)

$1,187,386 (0%)

$0 (0%)

$0 (0%)

Cash & Equivalents

$5,858,000 (-82.44%)

$33,363,228 (-11.03%)

$37,500,931 (311.03%)

$9,123,617 (153.20%)

Accumulated Other Comprehensive Income

-$3,332,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$287,478 (-2.46%)

$294,717 (74.30%)

$169,088 (-59.09%)

Trade & Non-Trade Payables

$612,000 (-83.35%)

$3,675,090 (82.79%)

$2,010,533 (166.28%)

$755,049 (-20.94%)

Accumulated Retained Earnings (Deficit)

-$110,671,000 (-40.49%)

-$78,774,468 (-33.98%)

-$58,794,910 (-33.96%)

-$43,891,002 (-34.97%)

Tax Assets

$9,837,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$373,000 (-52.59%)

$786,743 (0%)

$0 (0%)

$0 (0%)

Debt Current

$163,000 (-4.49%)

$170,656 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$210,000 (-65.91%)

$616,087 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$5,830,000 (30.66%)

$4,461,833 (121.92%)

$2,010,533 (166.28%)

$755,049 (-29.54%)

Liabilities Current

$5,620,000 (46.14%)

$3,845,746 (91.28%)

$2,010,533 (166.28%)

$755,049 (-29.54%)

Liabilities Non-Current

$210,000 (-65.91%)

$616,087 (0%)

$0 (0%)

$0 (0%)

IXHL Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$12,000 (0%)

$0 (0%)

$0 (0%)

$1,973,344 (140.05%)

Cost of Revenue

$0 (0%)

$0 (0%)

$6,338 (-99.31%)

$911,969 (102.50%)

Selling General & Administrative Expense

$17,174,000 (98.11%)

$8,668,821 (-0.53%)

$8,715,228 (23.02%)

$7,084,617 (336.00%)

Research & Development Expense

$12,879,000 (37.53%)

$9,364,796 (74.33%)

$5,371,821 (13.10%)

$4,749,514 (125.03%)

Operating Expenses

$30,053,000 (40.72%)

$21,356,203 (36.15%)

$15,686,225 (26.15%)

$12,434,174 (189.10%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$30,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$18,459,000 (7.61%)

-$19,979,558 (-34.06%)

-$14,903,909 (-31.05%)

-$11,372,799 (-142.10%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$18,459,000 (7.61%)

-$19,979,558 (-34.06%)

-$14,903,909 (-31.05%)

-$11,372,799 (-142.10%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$18,459,000 (7.61%)

-$19,979,558 (-34.06%)

-$14,903,909 (-31.05%)

-$11,372,799 (-142.10%)

Weighted Average Shares

$16,164,338 (1.85%)

$15,870,104 (31.32%)

$12,085,280 (-99.00%)

$1,208,528,003 (0.00%)

Weighted Average Shares Diluted

$16,164,338

-

-

-

Earning Before Interest & Taxes (EBIT)

-$18,429,000 (7.76%)

-$19,979,558 (-34.06%)

-$14,903,909 (-31.05%)

-$11,372,799 (-142.10%)

Gross Profit

$12,000 (0%)

$0 (0%)

-$6,338 (-100.60%)

$1,061,375 (185.54%)

Operating Income

-$30,041,000 (-40.67%)

-$21,356,203 (-36.09%)

-$15,692,563 (-37.98%)

-$11,372,799 (-189.44%)

IXHL Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$277,000 (41.91%)

-$476,873 (0%)

$0 (0%)

$29,277 (125.21%)

Net Cash Flow from Financing

$0 (0%)

$12,275,567 (-70.19%)

$41,184,687 (232.12%)

$12,400,730 (67.48%)

Net Cash Flow from Operations

-$15,845,000 (0.61%)

-$15,942,825 (-24.48%)

-$12,807,373 (-85.35%)

-$6,909,780 (-76.84%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$16,122,000 (-289.03%)

-$4,144,131 (-114.60%)

$28,377,314 (414.06%)

$5,520,227 (57.27%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$29,277 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$277,000 (41.91%)

-$476,873 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$54,717 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$12,330,284 (-70.06%)

$41,184,687 (232.12%)

$12,400,730 (66.02%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$140,000 (-2277.97%)

$6,428 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$8,928,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Depreciation Amortization & Accretion

$103,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

IXHL Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00%

-

-

53.80% (19.03%)

Profit Margin

-153825.00%

-

-

-576.30% (-0.84%)

EBITDA Margin

-152716.70%

-

-

-576.30% (-0.84%)

Return on Average Equity (ROAE)

-115.20% (-227.27%)

-35.20% (50.77%)

-71.50% (-177.63%)

92.10% (232.49%)

Return on Average Assets (ROAA)

-90.40% (-186.08%)

-31.60% (49.92%)

-63.10% (62.37%)

-167.70% (15.13%)

Return on Sales (ROS)

-153575.00%

-

-

-576.30% (-0.84%)

Return on Invested Capital (ROIC)

-661.00% (-136.07%)

1832.30% (34.12%)

1366.20% (-40.61%)

2300.20% (128.63%)

Dividend Yield

0% (0%)

0% (0%)

0%

-

Price to Earnings Ratio (P/E)

-2.56 (54.71%)

-5.65 (54.23%)

-12.34

-

Price to Sales Ratio (P/S)

3,960.29

-

-

-

Price to Book Ratio (P/B)

4.16 (184.54%)

1.46 (-73.44%)

5.5

-

Debt to Equity Ratio (D/E)

0.52 (828.57%)

0.06 (-5.08%)

0.06 (-39.18%)

0.1 (393.94%)

Earnings Per Share (EPS)

-1.15 (11.54%)

-1.3 (-4.00%)

-1.25 (-115.52%)

-0.58 (-68.12%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0.08 (141.18%)

Free Cash Flow Per Share (FCFPS)

-1 (3.67%)

-1.03 (2.36%)

-1.06 (-270.63%)

-0.29 (-77.64%)

Book Value Per Share (BVPS)

0.69 (-86.18%)

5.02 (79.16%)

2.8 (767.49%)

0.32 (124.01%)

Tangible Assets Book Value Per Share (TABVPS)

1.05 (-53.32%)

2.26 (-27.89%)

3.13 (711.92%)

0.39 (120.57%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (50.00%)

-4 (63.64%)

-11

-

Enterprise Value Over EBITDA (EV/EBITDA)

-2.06 (45.32%)

-3.77 (66.28%)

-11.18

-

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0.29 (-15.90%)

Current Ratio

2.88 (-68.03%)

9.02 (-52.13%)

18.84 (52.50%)

12.36 (212.55%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$16,122,000 (1.81%)

-$16,419,698 (-28.21%)

-$12,807,373 (-85.35%)

-$6,909,780 (-77.43%)

Enterprise Value (EV)

$37,770,952 (-49.84%)

$75,294,804 (-54.80%)

$166,584,513

-

Earnings Before Tax (EBT)

-$18,429,000 (7.76%)

-$19,979,558 (-34.06%)

-$14,903,909 (-31.05%)

-$11,372,799 (-142.10%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$18,326,000 (8.28%)

-$19,979,558 (-34.06%)

-$14,903,909 (-31.05%)

-$11,372,799 (-142.10%)

Invested Capital

$5,942,000 (1182.41%)

-$548,958 (66.36%)

-$1,631,856 (-196.77%)

-$549,871 (-25.27%)

Working Capital

$10,582,000 (-65.69%)

$30,840,141 (-14.02%)

$35,869,075 (318.36%)

$8,573,746 (170.94%)

Tangible Asset Value

$17,047,000 (-52.48%)

$35,873,273 (-5.30%)

$37,879,608 (306.05%)

$9,328,795 (120.22%)

Market Capitalization

$46,666,952 (-59.94%)

$116,486,561 (-37.49%)

$186,355,018

-

Average Equity

$16,021,000 (-71.78%)

$56,762,788 (172.39%)

$20,838,620 (268.74%)

-$12,349,753 (27.08%)

Average Assets

$20,415,000 (-67.72%)

$63,235,154 (167.90%)

$23,604,202 (248.02%)

$6,782,437 (185.34%)

Invested Capital Average

$2,788,000 (355.68%)

-$1,090,407 (0.04%)

-$1,090,864 (-120.64%)

-$494,416 (-5.89%)

Shares

15,873,113 (0.02%)

15,870,104 (31.32%)

12,085,280 (-99.00%)

1,208,528,003 (0.00%)